Cyanta Analytical Services and Global BioDevelopment Enter into Strategic Partnership

Cyanta Analytical Services, an analytical service provider to the pharmaceutical and medical device industry, and Global BioDevelopment, a consulting firm for life science companies, have finalized a business agreement in which each organization would share sales, marketing, and technical capabilities to help grow each other's business. Cyanta will utilize its sales and marketing team to promote the capabilities of the relationship while Global BioDevelopment will leverage its diverse industry connections to support the partnership.

Analytical work and medical device testing will be performed at Cyanta which operates cGMP/GLP facilities in St. Louis, MO. Global BioDevelopment will provide in-depth regulatory support to clients regarding FDA requirements and will assist with designing comprehensive programs which efficiently help clients achieve their development goals. By combining Global BioDevelopment's know-how of the FDA drug development process and Cyanta's analytical expertise, clients can be assured they are receiving industry leading quality service that will expedite their drug development program.

Dave Riggs was excited about the new business relationship. "Mike Lewandowski and the team at Global BioDevelopment have a superior understanding of the full medical device and pharmaceutical development process. Combine Mike's 10,000 foot view with our excellent project execution and customer service and you have a really powerful solution to offer clients."

Mr. Lewandowski echoed Mr. Riggs sentiments, "We are excited about working hand-in-hand with Cyanta. They have a great business development team and excellent technical team. Their analytical excellence and commitment to quality and our knowledge of the regulatory process make this a great relationship for us and our clients."

Learn more about Global BioDevelopment's pharmaceutical and medical device support services.